Lundbeck
HLUN-B.CO
$8.33
Share price
-5.27%
Change (1 day)
15.90%
Change (1 year)
Categories
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.
Market capitalization of Lundbeck (HLUN-B.CO)
Market cap: A$7.98 Billion
As of March 2025 Lundbeck has a market cap of A$7.98 Billion. This makes Lundbeck the world's 2672th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Lundbeck from 2005 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | A$7.98 B | -10.9% |
| 2024 | A$8.96 B | 29.78% |
| 2023 | A$6.90 B | 30% |
| 2022 | A$5.31 B | 460.61% |
| 2021 | A$0.94 B | -20.96% |
| 2020 | A$1.19 B | -17.27% |
| 2019 | A$1.44 B | -12.3% |
| 2018 | A$1.65 B | -4.53% |
| 2017 | A$1.73 B | 15% |
| 2016 | A$1.50 B | 20.2% |
| 2015 | A$1.25 B | 93.71% |
| 2014 | A$0.64 B | -13.59% |
| 2013 | A$0.74 B | 101.12% |
| 2012 | A$0.37 B | -42.27% |
| 2011 | A$0.64 B | 31.64% |
| 2010 | A$0.48 B | -10.51% |
| 2009 | A$0.54 B | -35.92% |
| 2008 | A$0.85 B | 1.88% |
| 2007 | A$0.83 B | -14.64% |
| 2006 | A$0.98 B | 15.97% |
| 2005 | A$0.84 B |